Jia Jie Biomedical Co Ltd (TWO:4109) — Market Cap & Net Worth
Market Cap & Net Worth: Jia Jie Biomedical Co Ltd (4109)
Jia Jie Biomedical Co Ltd (TWO:4109) has a market capitalization of $45.45 Million (NT$1.44 Billion) as of June 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #22334 globally and #1383 in its home market, demonstrating a -1.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jia Jie Biomedical Co Ltd's stock price NT$12.15 by its total outstanding shares 118736681 (118.74 Million). Review 4109 current and long-term liabilities to assess the company's total debt and financial obligations.
Jia Jie Biomedical Co Ltd Market Cap History: 2015 to 2026
Jia Jie Biomedical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $96.41 Million to $45.45 Million (-7.02% CAGR).
Jia Jie Biomedical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jia Jie Biomedical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Jia Jie Biomedical Co Ltd's market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.15x
Jia Jie Biomedical Co Ltd's market cap is 1.15 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $83.68 Million | $626.06 Million | $11.63 Million | 0.13x | 7.20x |
| 2017 | $78.31 Million | $521.75 Million | -$232.09 Million | 0.15x | N/A |
| 2018 | $51.63 Million | $402.03 Million | $2.47 Million | 0.13x | 20.87x |
| 2019 | $74.38 Million | $343.06 Million | -$24.48 Million | 0.22x | N/A |
| 2020 | $65.36 Million | $270.29 Million | -$31.93 Million | 0.24x | N/A |
| 2021 | $49.34 Million | $242.48 Million | $5.34 Million | 0.20x | 9.24x |
| 2022 | $54.13 Million | $317.72 Million | -$5.47 Million | 0.17x | N/A |
| 2023 | $63.34 Million | $332.76 Million | $144.15 Million | 0.19x | 0.44x |
| 2024 | $83.42 Million | $537.07 Million | $211.37 Million | 0.16x | 0.39x |
| 2025 | $57.98 Million | $485.40 Million | $50.26 Million | 0.12x | 1.15x |
Competitor Companies of 4109 by Market Capitalization
Companies near Jia Jie Biomedical Co Ltd in the global market cap rankings as of June 18, 2026.
Key companies related to Jia Jie Biomedical Co Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $204.31 Billion USD ( CHF161.60 Billion CHF).
- Danone SA (PA:BN): Ranked #550 globally with a market cap of $49.54 Billion USD ( €42.37 Billion EUR).
- Danone SA (F:BSND): Ranked #704 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €85.40 |
| #98 | Nestle S.A. | SW:NESN | $204.31 Billion | CHF79.09 |
| #550 | Danone SA | PA:BN | $49.54 Billion | €65.80 |
| #704 | Danone SA | F:BSND | $39.05 Billion | €12.80 |
Jia Jie Biomedical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jia Jie Biomedical Co Ltd's market cap moved from $96.41 Million to $ 45.45 Million, with a yearly change of -7.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$45.45 Million | -21.61% |
| 2025 | NT$57.98 Million | -30.49% |
| 2024 | NT$83.42 Million | +31.71% |
| 2023 | NT$63.34 Million | +17.01% |
| 2022 | NT$54.13 Million | +9.70% |
| 2021 | NT$49.34 Million | -24.51% |
| 2020 | NT$65.36 Million | -12.13% |
| 2019 | NT$74.38 Million | +44.08% |
| 2018 | NT$51.63 Million | -34.07% |
| 2017 | NT$78.31 Million | -6.43% |
| 2016 | NT$83.68 Million | -13.20% |
| 2015 | NT$96.41 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Jia Jie Biomedical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.45 Million USD |
| MoneyControl | $45.45 Million USD |
| MarketWatch | $45.45 Million USD |
| marketcap.company | $45.45 Million USD |
| Reuters | $45.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more